Kintara Therapeutics, Inc. (KTRA)
NASDAQ: KTRA · IEX Real-Time Price · USD
0.121
+0.015 (13.88%)
Apr 19, 2024, 4:00 PM EDT - Market closed
Kintara Therapeutics Stock Forecast
KTRA's stock price has decreased by -96.24% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for KTRA stock has a target of 14, which predicts an increase of 11,432.13% from the current stock price of 0.12.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jul 14, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for KTRA is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $14 | Hold → Strong Buy | Upgrades | $14 | +11,432.13% | Jul 14, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 29, 2022 |
| Dawson James | Dawson James | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 16, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $300 → $150 | Strong Buy | Maintains | $300 → $150 | +123,458.48% | Jan 20, 2022 |
| Aegis Capital | Aegis Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Sep 30, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.47
from -9.27
EPS Next Year
-0.39
from -0.47
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 7.8M | 22.1M |
| Avg | n/a | n/a | n/a | 7.6M | 21.4M |
| Low | n/a | n/a | n/a | 7.3M | 20.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 191.7% |
| Avg | - | - | - | - | 183.4% |
| Low | - | - | - | - | 172.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.48 | -0.40 | -0.39 |
| Avg | -0.47 | -0.39 | -0.38 |
| Low | -0.45 | -0.37 | -0.36 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.